Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng./ml. or less.
about
The role of empiric antibiotic treatment in preventing unnecessary prostate biopsies in asymptomatic patients with PSA levels between 4 and 10 ng/ml.Digital rectal examination skills: first training experiences, the motives and attitudes of standardized patients.Optimal baseline prostate-specific antigen level to distinguish risk of prostate cancer in healthy men between 40 and 69 years of ageIndividualized screening interval for prostate cancer based on prostate-specific antigen level: results of a prospective, randomized, population-based study.Rectal examination and urethral catheterization by medical students and house officers: taught but not used.Characterizing prostatic adenocarcinomas in men with a serum prostate specific antigen level of < 4.0 ng/mL.Prostate cancer detection with digital rectal examination, prostate-specific antigen, transrectal ultrasonography and biopsy in clinical urological practice.African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less.Preoperative parameters to predict incidental (T1a and T1b) prostate cancer.Recommandations de l’Association des urologues du Canada sur le dépistage et le diagnostic précoce du cancer de la prostate.Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer.Contemporary outcomes in the detection of prostate cancer using transrectal ultrasound-guided 12-core biopsy in Singaporean men with elevated prostate specific antigen and/or abnormal digital rectal examination.
P2860
Q34167201-BEB0C368-08A1-433B-9E0E-32C3EAF25BFFQ35067492-BE809315-CC3E-4922-BBCF-1F29066FECF0Q35639028-B7B5DCB2-7806-4DE0-8B69-AC5C68A05097Q35945224-77B1838C-5C07-4ACA-B084-47D3620427D2Q39545979-788374FB-76C4-44AD-93CA-B11EBE757F58Q39678200-3185D431-956C-4F98-9D86-2292DC08AB50Q39707623-B40C0494-7EE9-4154-91B8-4BB5F3F5A99BQ39768780-08B30C18-98B3-4BB4-B9A9-466A277E1D7AQ41810505-42047B07-D94B-4203-A308-E917F83A6D44Q43047248-46F241FC-87C5-44C5-864F-83BAD8E0F28EQ47123251-D92277E2-1E9F-40C1-B3E7-3F52E94C0707Q50034009-E4272395-D38D-42A8-8A33-D5D291794924Q55059376-227363E5-9E7A-41E9-90BF-9061893C5B92
P2860
Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng./ml. or less.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Digital rectal examination for ...... n levels of 4 ng./ml. or less.
@en
Digital rectal examination for ...... n levels of 4 ng./ml. or less.
@nl
type
label
Digital rectal examination for ...... n levels of 4 ng./ml. or less.
@en
Digital rectal examination for ...... n levels of 4 ng./ml. or less.
@nl
prefLabel
Digital rectal examination for ...... n levels of 4 ng./ml. or less.
@en
Digital rectal examination for ...... n levels of 4 ng./ml. or less.
@nl
P2093
P1476
Digital rectal examination for ...... n levels of 4 ng./ml. or less.
@en
P2093
P304
P356
10.1097/00005392-199903000-00027
P407
P577
1999-03-01T00:00:00Z